Sanofi Agrees to $315 Million Settlement Over Genzyme Suit
31 Outubro 2019 - 3:43AM
Dow Jones News
By Carlo Martuscelli
Sanofi SA (SAN.FR) said Thursday that it has agreed to a $315
million payout in a law suit that relates to its acquisition of
Genzyme Corp. in 2011.
Sanofi said that the settlement concerns certain contingent
value rights that were released to former Genzyme shareholders as
part of the deal. These rights can be related to monetary
entitlements linked to drug development milestone.
The French company said that with this settlement the CVRs will
cease to trade and the lawsuit will be dismissed.
Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com;
@carlomartu
(END) Dow Jones Newswires
October 31, 2019 02:28 ET (06:28 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Sanofi (EU:SAN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
